Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Enterprise Value (EV) 

Microsoft Excel

Current Enterprise Value (EV)

Bristol-Myers Squibb Co., current enterprise value calculation

Microsoft Excel
Current share price (P) $47.51
No. shares of common stock outstanding 2,035,080,810
US$ in millions
Common equity (market value)1 96,687
Add: Preferred stock, $2 convertible series, par value $1 per share (per books)
Add: Noncontrolling interest (per books) 53
Total equity 96,740
Add: Short-term debt obligations (per books) 2,046
Add: Long-term debt, excluding current portion (per books) 47,603
Total equity and debt 146,389
Less: Cash and cash equivalents 10,346
Less: Marketable debt securities 513
Enterprise value (EV) 135,530

Based on: 10-K (reporting date: 2024-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 47.51 × 2,035,080,810


Historical Enterprise Value (EV)

Bristol-Myers Squibb Co., EV calculation

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Share price1, 2 $56.15 $48.71 $72.25 $67.14 $60.00
No. shares of common stock outstanding1 2,029,312,023 2,022,193,411 2,098,775,978 2,179,712,820 2,240,475,153
US$ in millions
Common equity (market value)3 113,946 98,501 151,637 146,346 134,429
Add: Preferred stock, $2 convertible series, par value $1 per share (book value)
Add: Noncontrolling interest (book value) 53 55 57 60 60
Total equity 113,999 98,556 151,694 146,406 134,489
Add: Short-term debt obligations (book value) 2,046 3,119 4,264 4,948 2,340
Add: Long-term debt, excluding current portion (book value) 47,603 36,653 35,056 39,605 48,336
Total equity and debt 163,648 138,328 191,014 190,959 185,165
Less: Cash and cash equivalents 10,346 11,464 9,123 13,979 14,546
Less: Marketable debt securities 513 816 130 2,987 1,285
Enterprise value (EV) 152,789 126,048 181,761 173,993 169,334

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Bristol-Myers Squibb Co. Annual Report.

3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 56.15 × 2,029,312,023


Common Equity (Market Value)
The common equity exhibited a general upward trend from 2020 through 2022, increasing from approximately $134.4 billion to $151.6 billion. However, a significant decline occurred in 2023, with a decrease to around $98.5 billion, followed by a recovery in 2024 to approximately $114 billion. This pattern suggests a period of volatility or external influence affecting market valuation in 2023, with partial stabilization thereafter.
Total Equity
Total equity mirrored the trend of common equity closely, escalating from about $134.5 billion in 2020 to $151.7 billion in 2022, then sharply declining to $98.6 billion in 2023 before rebounding to nearly $114 billion in 2024. The parallel movement indicates that the components of total equity other than common equity remained relatively consistent during these periods.
Total Equity and Debt
Total equity and debt rose modestly from approximately $185.2 billion in 2020 to $191 billion in 2022, signaling steady leverage and capital structure. Subsequently, a marked contraction to $138.3 billion occurred in 2023, corresponding with the decline seen in equity figures. The figure then increased to $163.6 billion in 2024, indicating a partial restoration of financial resources or capital commitment.
Enterprise Value (EV)
Enterprise value experienced a gradual increase from $169.3 billion in 2020 to $181.8 billion in 2022, reflecting growing market valuation and debt levels. In 2023, a sharp decrease to $126 billion was observed, aligning with declines in equity and total capitalization, followed by an increase to $152.8 billion in 2024. The EV trend underscores a notable disruption in 2023, impacting both market perceptions and the company's valuation base, with a trend toward recovery the following year.